Literature DB >> 2542184

Rescue and replication of the adeno-associated virus 2 genome in mortal and immortal human cells.

P Nahreini1, A Srivastava.   

Abstract

Productive infection of the adeno-associated virus (AAV) as well as rescue of the AAV genome from a recombinant plasmid and its subsequent replication in established cell lines are dependent upon coinfection with adenovirus. A comparative study of AAV infection and rescue/replication was carried out in mortal and immortal human cells. AAV DNA replication as well as assembly and release of the progeny virions were significantly delayed in normal diploid cells, which have a limited replicative potential, compared with polyploid cells, which have an unlimited proliferative potential. Rescue of the AAV genome from a recombinant plasmid and its subsequent replication were similarly delayed in mortal cells. The delay in AAV rescue/replication appeared to be unrelated to the adenovirus-encoded functions. The putative host-cell component required for AAV replication may be suboptimally induced in normal human diploid cells, which offer a useful model system for a natural AAV infection.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2542184     DOI: 10.1159/000150078

Source DB:  PubMed          Journal:  Intervirology        ISSN: 0300-5526            Impact factor:   1.763


  12 in total

1.  Characterization of wild-type adeno-associated virus type 2-like particles generated during recombinant viral vector production and strategies for their elimination.

Authors:  X S Wang; B Khuntirat; K Qing; S Ponnazhagan; D M Kube; S Zhou; V J Dwarki; A Srivastava
Journal:  J Virol       Date:  1998-07       Impact factor: 5.103

2.  Rescue and autonomous replication of adeno-associated virus type 2 genomes containing Rep-binding site mutations in the viral p5 promoter.

Authors:  X S Wang; A Srivastava
Journal:  J Virol       Date:  1998-06       Impact factor: 5.103

3.  Adeno-associated virus type 2-mediated transfer of ecotropic retrovirus receptor cDNA allows ecotropic retroviral transduction of established and primary human cells.

Authors:  K Qing; T Bachelot; P Mukherjee; X S Wang; L Peng; M C Yoder; P Leboulch; A Srivastava
Journal:  J Virol       Date:  1997-07       Impact factor: 5.103

4.  Rescue and replication of adeno-associated virus type 2 as well as vector DNA sequences from recombinant plasmids containing deletions in the viral inverted terminal repeats: selective encapsidation of viral genomes in progeny virions.

Authors:  X S Wang; S Ponnazhagan; A Srivastava
Journal:  J Virol       Date:  1996-03       Impact factor: 5.103

5.  Transduction of folate receptor cDNA into cervical carcinoma cells using recombinant adeno-associated virions delays cell proliferation in vitro and in vivo.

Authors:  X L Sun; B R Murphy; Q J Li; S Gullapalli; J Mackins; H N Jayaram; A Srivastava; A C Antony
Journal:  J Clin Invest       Date:  1995-09       Impact factor: 14.808

6.  Adeno-associated virus type 2 DNA replication in vivo: mutation analyses of the D sequence in viral inverted terminal repeats.

Authors:  X S Wang; K Qing; S Ponnazhagan; A Srivastava
Journal:  J Virol       Date:  1997-04       Impact factor: 5.103

7.  A novel terminal resolution-like site in the adeno-associated virus type 2 genome.

Authors:  X S Wang; A Srivastava
Journal:  J Virol       Date:  1997-02       Impact factor: 5.103

8.  Construction of a recombinant human parvovirus B19: adeno-associated virus 2 (AAV) DNA inverted terminal repeats are functional in an AAV-B19 hybrid virus.

Authors:  C H Srivastava; R J Samulski; L Lu; S H Larsen; A Srivastava
Journal:  Proc Natl Acad Sci U S A       Date:  1989-10       Impact factor: 11.205

9.  Modification of some biological properties of HeLa cells containing adeno-associated virus DNA integrated into chromosome 17.

Authors:  C Walz; J R Schlehofer
Journal:  J Virol       Date:  1992-05       Impact factor: 5.103

10.  Transcriptional transactivation of parvovirus B19 promoters in nonpermissive human cells by adenovirus type 2.

Authors:  S Ponnazhagan; M J Woody; X S Wang; S Z Zhou; A Srivastava
Journal:  J Virol       Date:  1995-12       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.